Chiba, Japan

Arata Ohnishi

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arata Ohnishi: Innovator in Biomarkers for Psychiatric and Neurological Disorders

Introduction

Arata Ohnishi is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of psychiatric and neurological disorders through his innovative research and inventions. His work focuses on developing biomarkers that can aid in the diagnosis of these complex conditions.

Latest Patents

Ohnishi holds a patent for a biomarker specifically designed for psychiatric and neurological disorders. The purpose of this invention is to provide a reliable biomarker for diagnosing these disorders, along with a test kit and method for conducting such tests. The invention is based on the discovery of a significant increase in the concentration of free κ immunoglobulin chains and free λ immunoglobulin chains in the blood samples of patients suffering from psychiatric and neurological disorders. This biomarker allows for easier testing and diagnosis using blood samples, enabling more effective assessments when combined with inflammatory cytokines present in the blood.

Career Highlights

Ohnishi is associated with Resvo Inc., where he continues to advance his research in the field of biomarkers. His work has the potential to revolutionize the way psychiatric and neurological disorders are diagnosed and treated.

Collaborations

Ohnishi collaborates with notable colleagues, including Takafumi Minamimoto and Tetsuya Suhara. Their combined expertise contributes to the innovative research being conducted at Resvo Inc.

Conclusion

Arata Ohnishi's contributions to the field of psychiatric and neurological disorders through his patented biomarker represent a significant advancement in medical diagnostics. His work not only enhances the understanding of these disorders but also paves the way for more effective testing methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…